CD4 and tuberculosis: The meta-analysis of these three studies indicated that antiretroviral therapy is strongly associated with a reduction in tuberculosis incidence in adults with CD4 counts above 350 cells/μl (HR 0.43, 95% CI 0.30 to 0.63; p-value for effect <0.001; p-value for heterogeneity = 0.774).